CORRELATION OF BASELINE CIRCULATING VG9VD2 T CELL COUNTS AND PHARMACODYNAMIC ACTIVITY OF ICT01 IN CANCER PATIENTS: PRELIMINARY RESULTS FROM EVICTION AND A NOVEL PATIENT ENRICHMENT STRATEGY

被引：0
|
作者：
Valentin, Emmanuel [1 ]
de Gassart, Aude [1 ]
Brune, Patrick [1 ]
Ghigo, Clement [1 ]
Agaugue, Sophie [2 ]
Olive, Daniel [2 ]
Frohna, Paul [1 ]
机构：
[1] Imcheck Therapeut, Marseille, France
[2] CRCM, INSERM, U1068, Marseille, France
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
528
引用
收藏
页码：A558 / A558
页数：1
相关论文
共 5 条
  • [1] ICT01, AN ANTI-BTN3A MAB THAT ACTIVATES VG9VD2 T CELLS, PLUS INTERLEUKIN-2: A POTENT AND PROMISING COMBINATION FOR CANCER IMMUNOTHERAPY
    de Gassart, Aude
    Brune, Patrick
    Suong, L. E.
    Agaugue, Sophie
    Valentin, Emmanuel
    Sims, Jennifer
    Olive, Daniel
    Frohna, Paul
    Hoet, Rene
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A268 - A269
  • [2] BUTYROPHILIN-3A IS EXPRESSED IN MULTIPLE SOLID TUMORS: TRANSLATIONAL RESEARCH SUPPORTING THE EVICTION STUDY WITH ICT01, AN ANTI-BTN3A MAB ACTIVATING VG9VD2 T-CELLS
    Ghigo, Clement
    de Gassard, Aude
    Brune, Patrick
    Imbert, Caroline
    Demerle, Clemence
    Marie-Sarah, Rouviere
    Hoet, Rene
    Olive, Daniel
    Valentin, Emmanuel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A2 - A2
  • [3] EVICTION STUDY: PRELIMINARY RESULTS IN SOLID TUMOR PATIENTS WITH ICT01, A FIRST-IN-CLASS, GAMMA9 DELTA2 T CELL ACTIVATING ANTIBODY TARGETING BUTYROPHILIN-3A
    Marabelle, Aurelien
    Jungels, Christiane
    De Bono, Johann
    Vey, Norbert
    Wermke, Martin
    Garralda, Elena
    de Gassart, Aude
    Brune, Patrick
    Valentin, Emmanuel
    Iche, Marina
    Olive, Daniel
    Frohna, Paul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A194 - A195
  • [4] ICT01, AN ANTI-BTN3A MAB, AND NL-201, AN ALPHA-INDEPENDENT IL-2/IL-15 AGONIST, COMBINE TO ELICIT A POTENT ANTI-TUMOR RESPONSE BY SYNERGISTICALLY STIMULATING VG9VD2 T CELL ACTIVATION AND PROLIFERATION
    De Gassart, Aude
    Brune, Patrick
    Mairesse, Maelle
    Agaugue, Sophie
    Swanson, Ryan
    Madakamutil, Loui
    Walkey, Carl
    Frohna, Paul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A592 - A592
  • [5] The combination of ICT01, a γ9δ2 T cell-activating mAb, plus pembrolizumab induces a broad antitumor immune response and disease control in patients with CPI-failure melanoma, NSCLC and bladder cancer: EVICTION trial
    Champiat, S.
    Wermke, M.
    Vicier, C.
    De Bono, J. S.
    Jungels, C.
    Vey, N.
    Kotecki, N.
    Wetzko, K.
    Ruhnke, L.
    Garralda, E.
    De Aguiar, V. Galvao
    Lorusso, P.
    De Gassart, A.
    Valentin, E.
    Brune, P.
    Iche, M.
    Leparquier, C.
    Olive, D.
    Marabelle, A.
    Frohna, P. A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S877 - S878
1